604 related articles for article (PubMed ID: 12218210)
41. [Inflammatory myofibroblastic tumors].
Sirvent N; Coindre JM; Pedeutour F
Ann Pathol; 2002 Dec; 22(6):453-60. PubMed ID: 12594387
[TBL] [Abstract][Full Text] [Related]
42. [Imprint cytological features of soft tissue sarcomas].
Sonobe H
Rinsho Byori; 1999 Jul; 47(7):614-21. PubMed ID: 10442039
[TBL] [Abstract][Full Text] [Related]
43. Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study.
O'Sullivan MJ; Kyriakos M; Zhu X; Wick MR; Swanson PE; Dehner LP; Humphrey PA; Pfeifer JD
Mod Pathol; 2000 Dec; 13(12):1336-46. PubMed ID: 11144931
[TBL] [Abstract][Full Text] [Related]
44. Beta-catenin expression in pediatric fibroblastic and myofibroblastic lesions: a study of 100 cases.
Thway K; Gibson S; Ramsay A; Sebire NJ
Pediatr Dev Pathol; 2009; 12(4):292-6. PubMed ID: 18939887
[TBL] [Abstract][Full Text] [Related]
45. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts.
Oda Y; Tamiya S; Oshiro Y; Hachitanda Y; Kinukawa N; Iwamoto Y; Tsuneyoshi M
Pathol Int; 2002 Sep; 52(9):595-606. PubMed ID: 12406189
[TBL] [Abstract][Full Text] [Related]
46. Sirtuin 1 (SIRT1): a potential immunohistochemical marker and therapeutic target in soft tissue neoplasms with myoid differentiation.
Dickson BC; Riddle ND; Brooks JS; Pasha TL; Zhang PJ
Hum Pathol; 2013 Jun; 44(6):1125-30. PubMed ID: 23332867
[TBL] [Abstract][Full Text] [Related]
47. A novel ALK rearrangement in an inflammatory myofibroblastic tumor in a neonate.
Owusu-Brackett N; Johnson R; Schindel DT; Koduru P; Cope-Yokoyama S
Cancer Genet; 2013; 206(9-10):353-6. PubMed ID: 24290361
[TBL] [Abstract][Full Text] [Related]
48. [Recent advances in diagnosis of malignant soft tissue tumor of urinary bladder].
Cheng L; Huang WB; Teng XD; Xu JW; Zhang SB
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):126-30. PubMed ID: 20388385
[No Abstract] [Full Text] [Related]
49. Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.
Panagopoulos I; Nilsson T; Domanski HA; Isaksson M; Lindblom P; Mertens F; Mandahl N
Int J Cancer; 2006 Mar; 118(5):1181-6. PubMed ID: 16161041
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics.
Hung YP; Fletcher CDM; Hornick JL
Histopathology; 2018 Oct; 73(4):634-644. PubMed ID: 29863809
[TBL] [Abstract][Full Text] [Related]
51. RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors.
Patel AS; Murphy KM; Hawkins AL; Cohen JS; Long PP; Perlman EJ; Griffin CA
Cancer Genet Cytogenet; 2007 Jul; 176(2):107-14. PubMed ID: 17656252
[TBL] [Abstract][Full Text] [Related]
52. ALK probe rearrangement in a t(2;11;2)(p23;p15;q31) translocation found in a prenatal myofibroblastic fibrous lesion: toward a molecular definition of an inflammatory myofibroblastic tumor family?
Sirvent N; Hawkins AL; Moeglin D; Coindre JM; Kurzenne JY; Michiels JF; Barcelo G; Turc-Carel C; Griffin CA; Pedeutour F
Genes Chromosomes Cancer; 2001 May; 31(1):85-90. PubMed ID: 11284039
[TBL] [Abstract][Full Text] [Related]
53. Anaplastic lymphoma kinase protein expression, genetic abnormalities, and phosphorylation in soft tissue tumors: Phosphorylation is associated with recurrent metastasis.
Ishibashi Y; Miyoshi H; Hiraoka K; Arakawa F; Haraguchi T; Nakashima S; Hashiguchi T; Shoda T; Hamada T; Okawa T; Higuchi F; Shiba N; Nagata K; Ohshima K
Oncol Rep; 2015 Apr; 33(4):1667-74. PubMed ID: 25683346
[TBL] [Abstract][Full Text] [Related]
54. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.
Lawrence B; Perez-Atayde A; Hibbard MK; Rubin BP; Dal Cin P; Pinkus JL; Pinkus GS; Xiao S; Yi ES; Fletcher CD; Fletcher JA
Am J Pathol; 2000 Aug; 157(2):377-84. PubMed ID: 10934142
[TBL] [Abstract][Full Text] [Related]
55. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.
Rabban JT; Zaloudek CJ; Shekitka KM; Tavassoli FA
Am J Surg Pathol; 2005 Oct; 29(10):1348-55. PubMed ID: 16160478
[TBL] [Abstract][Full Text] [Related]
56. For staining of ALK protein, the novel D5F3 antibody demonstrates superior overall performance in terms of intensity and extent of staining in comparison to the currently used ALK1 antibody.
Taheri D; Zahavi DJ; Del Carmen Rodriguez M; Meliti A; Rezaee N; Yonescu R; Ricardo BF; Dolatkhah S; Ning Y; Bishop JA; Netto GJ; Sharma R
Virchows Arch; 2016 Sep; 469(3):345-50. PubMed ID: 27271275
[TBL] [Abstract][Full Text] [Related]
57. ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder.
Tsuzuki T; Magi-Galluzzi C; Epstein JI
Am J Surg Pathol; 2004 Dec; 28(12):1609-14. PubMed ID: 15577680
[TBL] [Abstract][Full Text] [Related]
58. p63 immunohistochemical staining is limited in soft tissue tumors.
Jo VY; Fletcher CD
Am J Clin Pathol; 2011 Nov; 136(5):762-6. PubMed ID: 22031315
[TBL] [Abstract][Full Text] [Related]
59. Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: an immunohistochemical study with diagnostic implications.
Chen BJ; Mariño-Enríquez A; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Aug; 36(8):1119-28. PubMed ID: 22790852
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors.
Suda A; Sato T; Watanabe Y; Yamakawa M; Imai Y
Nihon Seikeigeka Gakkai Zasshi; 1990 Sep; 64(9):814-23. PubMed ID: 2172422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
